Showing results (121-130 of 225) with videos related to

Sort By:
Pageof 23
The Cochrane Database of Systematic Reviews|December 7, 2018
Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adultsJacqueline Dinnes, Jonathan J Deeks, Naomi Chuchu, et al.
The Cochrane Database of Systematic Reviews|December 7, 2018
Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adultsLavinia Ferrante di Ruffano, Jacqueline Dinnes, Naomi Chuchu, et al.
RMD Open|March 7, 2024
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validationAbhishek Abhishek, Matthew Grainge, Tim Card, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 31, 2020
An algorithm for diagnosing IgE-mediated food allergy in study participants who do not undergo food challengeMaeve M Kelleher, Nicola Jay, Michael R Perkin, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2014
Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis preventionEric L Simpson, Joanne R Chalmers, Jon M Hanifin, et al.
The British Journal of Dermatology|May 13, 2024
Diagnostic accuracy of autofluorescence-Raman microspectroscopy for surgical margin assessment during Mohs micrographic surgery of basal cell carcinomaRadu A Boitor, Sandeep Varma, Ashish Sharma, et al.
Biomedical Optics Express|May 17, 2021
Clinical integration of fast Raman spectroscopy for Mohs micrographic surgery of basal cell carcinomaRadu Boitor, Coen de Wolf, Frank Weesie, et al.
Rheumatology Advances in Practice|June 15, 2022
Incidence and pattern of mycophenolate discontinuation associated with abnormal monitoring blood-test results: cohort study using data from the Clinical Practice Research Datalink AurumGeorgina Nakafero, Matthew J Grainge, Tim Card, et al.
Health Technology Assessment (Winchester, England)|April 14, 2017
A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trialJoanne R Chalmers, Fenella Wojnarowska, Gudula Kirtschig, et al.
The Cochrane Database of Systematic Reviews|December 7, 2018
Optical coherence tomography for diagnosing skin cancer in adultsLavinia Ferrante di Ruffano, Jacqueline Dinnes, Jonathan J Deeks, et al.
Pageof 23